Protein profiling of isolated leukocytes, myofibroblasts, epithelial, basal, and endothelial cells from normal, hyperplastic, cancerous, and inflammatory human prostate tissues

Journal of Cancer

Volumn 1, Issue 1, 2010, Pages 70-79

  Khamis, Zahraa I ^a   Iczkowski, Kenneth A ^b   Sahab, Ziad J ^a   AmySang, Qing Xiang ^a  

^a FLORIDA STATE UNIVERSITY   (United States)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

Inflammation; Magnetic bead cell separation; Prostate cancer; Protein biomarkers; Tumor microenvironment; Tumorigenesis

Indexed keywords

ALPHA6 INTEGRIN; GUANINE NUCLEOTIDE BINDING PROTEIN; INTERLEUKIN 18 RECEPTOR; INTERLEUKIN 1BETA CONVERTING ENZYME; LEUCINE RICH REPEAT KINASE 2; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; NON RECEPTOR PROTEIN TYROSINE PHOSPHATASE 12; RAP1 PROTEIN; RETINOIC ACID BINDING PROTEIN; WNT3 PROTEIN;

ARTICLE; BASAL CELL; CANCER INVASION; CELL ISOLATION; DOWN REGULATION; ENDOTHELIUM CELL; EPITHELIUM CELL; HUMAN; HUMAN CELL; INFLAMMATION; LEUKOCYTE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MICROENVIRONMENT; MOLECULAR MECHANICS; MYOFIBROBLAST; PROSTATE CANCER; PROSTATE HYPERTROPHY; PROSTATITIS; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEOMICS; PROTO ONCOGENE; STROMA CELL; TUMOR GROWTH;

EID: 79956279202     PISSN: None     EISSN: 18379664     Source Type: Journal    
DOI: 10.7150/jca.1.70     Document Type: Article

References (53)

1. Tuxhorn JA, Ayala GE, Rowley DR. Reactive stroma in prostate cancer progression. Journal of Urology 2001;166(6):2472-2483.
2. Olumi AF, Grossfeld GD, Hayward SW, Carroll PR, Tisty TD, Cunha GR. Carcinoma-associated fibroblasts direct tumor progression of initiated human prostatic epithelium. Cancer Research 1999;59(19):5002-5011.
3. Man YG, Shen T, Zhao YG, Sang QXA. Focal prostate basal cell layer disruptions and leukocyte infiltration are correlated events: A potential mechanism for basal cell layer disruptions and tumor invasion. Cancer Detection and Prevention 2005;29(2):161-169.
4. Fidler IJ. Timeline - The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited. Nature Reviews Cancer 2003;3(6):453-458.
5. Mueller MM, Fusenig NE. Friends or foes - Bipolar effects of the tumour stroma in cancer. Nature Reviews Cancer 2004;4(11):839-849.
6. Tlsty TD, Hein PW. Know thy neighbor: stromal cells can contribute oncogenic signals. Current Opinion in Genetics & Development 2001;11(1):54-59.
7. Shimura S, Yang G, Ebara S, Wheeler TM, Frolov A, Thompson TC. Reduced infiltration of tumor-associated macrophages in human prostate cancer: Association with cancer progression. Cancer Research 2000;60(20):5857-5861.
8. Man YG, Gardner WA. Focal degeneration of basal cells and the resultant auto-immunoreactions: A novel mechanism for prostate tumor progression and invasion. Medical Hypotheses 2008;70(2):387-408.
9. Dakhova O, Ozen M, Creighton CJ, Li RL, Ayala G, Rowley D, Ittmann M. Global Gene Expression Analysis of Reactive Stroma in Prostate Cancer. Clinical Cancer Research 2009;15(12):3979-3989.
10. Richardson AM, Woodson K, Wang Y, Rodriguez-Canales J, Erickson HS, Tangrea MA, Novakovic K, Gonzalez S, Velasco A, Kawasaki ES, Emmert-Buck MR, Chuaqui RF, Player A. Global expression analysis of prostate cancer-associated stroma and epithelia. Diagnostic Molecular Pathology 2007;16(4):189-197.
11. Min H, Yao J, Allinen M, Cai L, Polyak K. The role of the tumor microenvironment in breast cancer progression. Breast Cancer Research 2005;7:S7-S7.
12. Sahab ZJ, Suh Y, Sang QXA. Isoelectric point-based prefractionation of proteins from crude biological samples prior to two-dimensional gel electrophoresis. Journal of Proteome Research 2005;4(6):2266-2272.
13. Sahab ZJ, Iczkowski KA, Sang QXA. Anion exchange fractionation of serum proteins versus albumin elimination. Analytical Biochemistry 2007;368(1):24-32.
14. Karas M, Hill Enkamp F. Laser Desorpti on Ioni zati on of Protei ns with Molecular Masses Exceeding 10000 Daltons. Analytical Chemistry 1988;60(20):2299-2301.
15. Tanaka K, Waki H, Ido Y, Akita S, Yoshida Y, Yohida T. Protein and polymer analyses up to m/z 100,000 by laser ionization time-of-flight mass spectrometry. Rapid Communications in Mass Spectrometry 1988;2(8):151-153.
16. Schiller J, Arnhold J, Benard S, Muller M, Reichl S, Arnold K. Lipid analysis by matrix-assisted laser desorption and ionization mass spectrometry: A methodological approach. Analytical Biochemistry 1999;267(1):46-56.
17. Goldfarb RH, Liotta LA. Proteolytic-Enzymes in Cancer Invasion and Metastasis. Seminars in Thrombosis and Hemostasis 1986;12(4):294-307.
18. Dawson LA, Maitland NJ, Turner AJ, Usmani BA. Stromal-epithelial interactions influence prostate cancer cell invasion by altering the balance of metallopeptidase expression. British Journal of Cancer 2004;90(8):1577-1582.
19. Coussens LM, Fingleton B, Matrisian LM. Cancer therapy -Matrix metalloproteinase inhibitors and cancer: Trials and tribulations. Science 2002;295(5564):2387-2392.
20. Ashida S, Nakagawa H, Katagiri T, Furihata M, Iiizumi M, Anazawa Y, Tsunoda T, Takata R, Kasahara K, Miki T, Fujioka T, Shuin T, Nakamura Y. Molecular features of the transition from prostatic intraepithelial neoplasia (PIN) to prostate cancer: Genome-wide gene-expression profiles of prostate cancers and PINs. Cancer Research 2004;64(17):5963-5972.
21. Liu AJ, Wei LX, Gardner WA, Deng CX, Man YG. Correlated alterations in prostate basal cell layer and basement membrane. International Journal of Biological Sciences 2009;5(3):276-285.
22. Polyak K, Hu M. Do myoepithelial cells hold the key for breast tumor progression? Journal of Mammary Gland Biology and Neoplasia 2005;10(3):231-247.
23. Allinen M, Beroukhim R, Cai L, Brennan C, Lahti-Domenici J, Huang HY, Porter D, Hu M, Chin L, Richardson A, Schnitt S, Sellers WR, Polyak K. Molecular characterization of the tumor microenvironment in breast cancer. Cancer Cell 2004;6(1):17-32.
24. Thornberry NA, Bull HG, Calaycay JR, Chapman KT, Howard AD, Kostura MJ, Miller DK, Molineaux SM, Weidner JR, Aunins J, Elliston KO, Ayala JM, Casano FJ, Chin J, Ding GJF, Egger LA, Gaffney EP, Limjuco G, Palyha OC, Raju SM, Rolando AM, Salley JP, Yamin TT, Lee TD, Shively JE, Maccross M, Mumford RA, Schmidt JA, Tocci MJ. A Novel Heterodimeric Cysteine Protease Is Required for Interleukin-1-Beta Processing in Monocytes. Nature 1992;356(6372):768-774.
25. Mariathasan S, Newton K, Monack DM, Vucic D, French DM, Lee WP, Roose-Girma M, Erickson S, Dixit VM. Differential activation of the inflammasome by caspase-1 adaptors ASC and Ipaf. Nature 2004;430(6996):213-218.
26. Deng CH, Zang ZJ, Sun XZ, Huang XH, Wang D, Wang H, Su S. The expression and significance of caspase-1 in tissue of benign prostatic hyperplasia. International Journal of Andrology 2005;28:120-120.
27. Winter RN, Kramer A, Borkowski A, Kyprianou N. Loss of caspase-1 and caspase-3 protein expression in human prostate cancer. Cancer Research 2001;61(3):1227-1232.
28. Akira S. The role of IL-18 in innate immunity. Current Opinion in Immunology 2000;12(1):59-63.
29. Bazan JF, Timans JC, Kastelein RA. A newly defined interleukin-1? Nature 1996;379(6566):591-591.
30. Gu Y, Kuida K, Tsutsui H, Ku G, Hsiao K, Fleming MA, Hayashi N, Higashino K, Okamura H, Nakanishi K, Kurimoto M, Tanimoto T, Flavell RA, Sato V, Harding MW, Livingston DJ, Su MSS. Activation of interferon-gamma inducing factor mediated by interleukin-1 beta converting enzyme. Science 1997;275(5297):206-209.
31. Parnet P, Garka KE, Bonnert TP, Dower SK, Sims JE. IL-1Rrp is a novel receptor-like molecule similar to the type I interleukin-1 receptor and its homologues T1/ST2 and IL-1R AcP. Journal of Biological Chemistry 1996;271(8):3967-3970.
32. Lebel-Binay S, Thiounn N, De Pinieux G, Vieillefond A, Debre B, Bonnefoy JY, Fridman WH, Pages F. IL-18 is produced by prostate cancer cells and secreted in response to interferons. International Journal of Cancer 2003;106(6):827-835.
33. Horiuchi H, Lippe R, McBride HM, Rubino M, Woodman P, Stenmark H, Rybin V, Wilm M, Ashman K, Mann M, Zerial M. A novel Rab5 GDP/GTP exchange factor complexed to Rabaptin-5 links nucleotide exchange to effector recruitment and function. Cell 1997;90(6):1149-1159.
34. Stenmark H, Vitale G, Ullrich O, Zerial M. Rabaptin-5 Is a Direct Effector of the Small Gtpase Rab5 in Endocytic Membrane-Fusion. Cell 1995;83(3):423-432.
35. Emami KH, Corey E. When prostate cancer meets bone: Control by wnts. Cancer Letters 2007;253(2):170-179.
36. Hall CL, Kang SN, MacDougald OA, Keller ET. Role of Wnts in prostate cancer bone metastases. Journal of Cellular Biochemistry 2006;97(4):661-672.
37. Lessard L, Stuible M, Tremblay ML. The two faces of PTP1B in cancer. Biochimica Et Biophysica Acta-Proteins and Proteomics 2010;1804(3):613-619.
38. Woodfordthomas TA, Rhodes JD, Dixon JE. Expression of a Protein Tyrosine Phosphatase in Normal and Nu-Src-Transformed Mouse 3T3 Fibroblasts. Journal of Cell Biology 1992;117(2):401-414.
39. Brownshimer S, Johnson KA, Hill DE, Bruskin AM. Effect of Protein Tyrosine Phosphatase-1B Expression on Transformation by the Human Neu Oncogene. Cancer Research 1992;52(2):478-482.
40. Wiener JR, Kerns BJM, Harvey EL, Conaway MR, Iglehart JD, Berchuck A, Bast RC. Overexpression of the Protein-Tyrosine-Phosphatase Ptp1B in Human Breast-Cancer -Association with P185(C-Erbb-2) Protein Expression. Journal of the National Cancer Institute 1994;86(5):372-378.
41. Bjorge JD, Pang A, Fujita DJ. Identification of protein-tyrosine phosphatase 1B as the major tyrosine phosphatase activity capable of dephosphorylating and activating c-Src in several human breast cancer cell lines. Journal of Biological Chemistry 2000;275(52):41439-41446.
42. Wu CY, Zhang L, Bourne PA, Reeder JE, di Sant'Agnese PA, Yao JL, Na YQ, Huang JT. Protein tyrosine phosphatase PTPIB is involved in neuroendocrine differentiation of prostate cancer. Prostate 2006;66(11):1125-1135.
43. Miura K, Jacques KM, Stauffer S, Kubosaki A, Zhu KJ, Hirsch DS, Resau J, Zheng Y, Randazzo PA. ARAP1: A point of convergence for Arf and Rho signaling. Molecular Cell 2002;9(1):109-119.
44. Daniele T, Di Tullio G, Santoro M, Turacchio G, De Matteis MA. ARAP1 Regulates EGF Receptor Trafficking and Signalling. Traffic 2008;9(12):2221-2235.
45. Simova S, Klima M, Cermak L, Sourkova V, Andera L. Arf and Rho GAP adapter protein ARAP1 participates in the mobilization of TRAIL-R1/DR4 to the plasma membrane. Apoptosis 2008;13(3):423-436.
46. Budhu AS, Noy N. Direct channeling of retinoic acid between cellular retinoic acid-binding protein II and retinoic acid receptor sensitizes mammary carcinoma cells to retinoic acid-induced growth arrest. Molecular and Cellular Biology 2002;22(8):2632-2641.
47. Okuducu AF, Janzen V, Ko Y, Hahne JC, Lu H, Ma ZL, Albers P, Sahin A, Wellmann A, Scheinert P, Wernert N. Cellular retinoic acid-binding protein 2 is down-regulated in prostate cancer. International Journal of Oncology 2005;27(5):1273-1282.
48. Rabinovitz I, Nagle RB, Cress AE. Integrin Alpha-6 Expression in Human Prostate Carcinoma-Cells Is Associated with a Migratory and Invasive Phenotype in-Vitro and in-Vivo. Clinical & Experimental Metastasis 1995;13(6):481-491.
49. Demetriou MC, Pennington ME, Nagle RB, Cress AE. Extracellular alpha 6 integrin cleavage by urokinase-type plasminogen activator in human prostate cancer. Experimental Cell Research 2004;294(2):550-558.
50. Pawar SC, Demetriou MC, Nagle RB, Bowden GT, Cress AE. Integrin alpha 6 cleavage: A novel modification to modulate cell migration. Experimental Cell Research 2007;313(6):1080-1089.
51. King TE, Pawar SC, Majuta L, Sroka IC, Wynn D, Demetriou MC, Nagle RB, Porreca F, Cress AE. The Role of Alpha 6 Integrin in Prostate Cancer Migration and Bone Pain in a Novel Xenograft Model. Plos One 2008;3(10):e3535.
52. Ports MO, Nagle RB, Pond GD, Cress AE. Extracellular engagement of alpha 6 integrin blocks uPA mediated cleavage and prevents human prostate bone metastasis. Clinical & Experimental Metastasis 2009;26(7):871-871.
53. Cho SH, Goenka S, Henttinen T, Gudapati P, Reinikainen A, Eischen CM, Lahesmaa R, Boothby M. PARP-14, a member of the B aggressive lymphoma family, transduces survival signals in primary B cells. Blood 2009;113(11):2416-2425.